The ULTIMATE trials: are there advantages of ublituximab over teriflunomide in relapsing multiple sclerosis?
.
Source: Expert Opinion on Biological Therapy - Category: Drugs & Pharmacology Authors: Sheila A Doggrell Source Type: research
More News: Drugs & Pharmacology | Multiple Sclerosis